Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa
SIR -Strong genetic liability and common etiopathogenetic background have been suggested for Eating Disorders (ED). Several lines of evidence support a possible involvement of serotonin (5-HT) pathways in modulating eating behavior, since alteration in 5-HT activity has been consistently demonstrated in ED. Moreover, 5-HT disturbances seem to persist after recovery. 1 These findings and the efficacy of 5-HT reuptake inhibitors in the treatment of ED suggest the serotonin transporter (5-HTT) gene as a good candidate for genetic studies. A deletion (short variant = s)/insertion (long variant = l) functional polymorphism has been described within the promoter region of the 5-HTT gene (5-HTTLPR). 2 Studies of transfected cells in culture show that the long and short variants exhibit different transcriptional properties. In particular, basal transcriptional activity of the long variant is more than twice that of the short form. 3 We studied this polymorphism in a sample of 50 bulimic (BN), 56 anorexic (AN) patients (19 restricting and 37 binge-eating type) and 120 healthy controls, closely questioned to exclude any psychiatric disorder. Informed consent was obtained from all the subjects, females, unrelated and of Italian descent. Patients fulfilled DSM-IV diagnostic criteria and were sequentially recruited at the Eating Disorder Clinic and Research Unit at San Raffaele University Hospital, Milan. Genomic DNA was extracted from whole blood and the polymorphism was analyzed as previously described. 4 Statistical analysis was performed with 2 statistics and power calculation with the EPINFO program (version 6.04b, 1997).
5 Table 1 shows the distribution of 5-HTTLPR alleles and genotypes in our sample. Genotype frequencies in controls and both subtypes of AN patients are in Hardy-Weinberg (H-W) equilibrium, while the BN group shows a significant deviation due to a lowerthan-expected frequency of the l/l genotype. A highly significant difference in the distribution of both 5-HTTLPR genotypes ( 2 = 23.823, 6 df, P = 0.000) and allele ( 2 = 17.752, 3 df, P = 0.000) was observed among the groups.
Analysis of the 2 components, showed the main contribution was due to the BN group, and, to a lesser extent, to the binge-eating subgroup. The odds ratio (OR) for the genotypes containing the short allele was 7.667 (95% CI 2.590-22.690) for BN, 1.576 (95% CI 0.712-2.486) for AN binge-eating subtype, and 1.444 (95% CI 0.514-4.062) for AN restricting type. Power calculation on the whole ED sample revealed that, if the frequency of the allele at risk is 40%, our sample has a power of 75%, with ␣ = 0.05, to detect a genotype relative risk (GRR), of 2. However, the same calculation on AN sample showed a very limited power (15%) to detect a GRR of the above-mentioned magnitude. A false negative result cannot therefore be excluded.
The mean duration of illness in our AN group is 5.3 ± 4.4 yrs. Thus, it is possible that some of our AN patients will develop BN in the future. As regards the BN sample, only two patients had a previous AN diagnosis. Therefore, we cannot exclude that sampling factors have conditioned our results.
To our knowledge, this is the first report from an association study between 5-HTTLPR and BN. Hinney et al found no association between 5-HTTLPR and extreme obesity, underweight or AN. 6 However, their study had no healthy controls and the patients were not sex-matched. Furthermore, the 5-HTTLPR genotype distribution in their AN sample was not different from our sample.
Our results suggest that 5-HTTLPR may play a different role in AN and in BN, as subjects bearing one or two copies of the short allele showed a seven-fold increased risk of bulimia.
Obviously, biological heterogeneity, diagnostic uncertainty and the common problem of population stratification in association studies could play a role in our findings. Thus, given the well-known history of false positive results in psychiatric genetics, it is clear that replication in independent and larger samples is critical. Likewise, the deviation from H-W equilibrium in the BN group deserves further studies. H-W disequilibrium can be associated with different conditions.
Molecular Psychiatry
Assortative mating or inbreeding has not yet been described in BN. Even though an adaptive role by 5-HTT locus, meiotic drive, population drift, or a bottleneck effect due to the reported increased mortality in AN, 7 could be invoked to explain this observation, at present (and given our sample size) all these hypotheses appear largely speculative. Nevertheless, we cannot exclude that deviation from H-W is related to an etiopathogenetic effect of the 5-HTTLPR in BN.
In conclusion, our results seem to suggest that 5-HTTLPR could play different roles in conferring genetic susceptibility for ED.
Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
SIR -The unstable DNA hypothesis in major psychosis states that unstable trinucleotide repeats may play an etiological role in schizophrenia and bipolar affective disorder. The idea of investigating trinucleotide repeats originated several years ago from the clinical observation that genetic anticipation may take place in the intergenerational changes of age at disease onset. Based on clinical and molecular findings in the 'classical' unstable DNA diseases such as Huntington's and myotonic dystrophy, the evidence for genetic anticipation implies the presence of trinucleotide repeat expansion. Although the idea of genetic anticipation in complex diseases has been questioned (reviewed in Paterson et al), 1 the search for dynamic DNA mutations in psychiatric diseases has been one of the most 'dynamic' developments in psychiatric genetics with a number of interesting although quite controversial experimental findings.
Two recent publications in Molecular Psychiatry by Joober et al 2 and Moriniere et al 3 further extend the horizon of the field of trinucleotide repeats in schizophrenia. In the two studies, a monoclonal antibody named 1C2 that detects polyglutamine tracts, was used in Western blots made from proteins from individuals affected with adult-and childhood onset schizophrenia as well as controls. Several affected individuals revealed polyglutamine-containing proteins of 50-60 kDa which were absent in the control samples. There were some slight differences in the size of detected proteins, and at present it is not clear if differences are caused by the different length of polyglutamine tracts in the same type of protein or these are different proteins. Two earlier studies 4,5 used a similar design but much smaller samples and did not detect disease-related polyglutamine proteins. It is important to note that both the Joober et al and Moriniere et al studies have been performed using lymphoblastoid cells, ie Epstein-Barr virus (EBV) transformed lymphocytes. We recently detected an interesting phenomenon related to EBV transformation of lymphocytes and trinucleotide repeats which might be relevant to the detected polyglutamine-containing proteins in the lymphoblastoid cells.
In our developments for the direct detection of trinucleotide repeats, 6 we serendipitously noticed that DNA methylation at some (CAG) n /(CTG) n trinucleotide repeats may change under the influence of EBV transformation of lymphocytes. In our experiments, we analysed DNA samples from EBV transformed lymphoblastoids paired to their native predecessor lymphocytes from myotonic dystrophy patients. In one of our experiments, genomic DNA samples were digested with a methylation-sensitive restriction enzyme, Hha I (restriction site GCGC), followed by Southern blot-hybridization with a non-specific (CAG) n /(CTG) n probe (for more details on this approach see Petronis et al). 6 In native lymphocytes, the overwhelming majority of (CAG) n /(CTG) n expansion flanking regions were methylated (Figure 1 ). After the lymphocyte transformation with EBV, however, some of the (CAG) n /(CTG) n containing fragments underwent loss of methylation (Figure 1 ). The secondary hybridization of the same blots with a DNA probe pB750 which is specific to the myotonic dystrophy protein kinase gene (DM-PK), detected that the unmethylated (CAG) n /(CTG) n fragments actually belonged to the expanded DM-PK alleles. The loss of methylation after EBV-transformation was highly specific: the mutant DM-PK alleles were unmethylated selectively while the overwhelming majority of other (CAG) n /(CTG) n sequences, as suggested by their large molecular weight, seem to remain methylated. The (CAG) n / (CTG) n fragments in the wild-type DM-PK alleles of affected individuals were not methylated in either type of lymphocytes (data not shown).
The mechanism of such loss of methylation in the vicinity of trinucleotide expansion of DM-PK is not clear. Several scenarios can be considered. One of them is that DNA methylation is selectively lost during
